Search Results For:
- Search results for:
- CEPI CfP3i Vaccine Funding Agreement Template
(Click + to show provisions)
Agreement title
Effective date
Partner type
Technology
Development stage
CEPI CfP3i Vaccine Funding Agreement Template
2018
Funder
Industry
Industry
Vaccine
Preclinical
Early clinical (through Phase 2)
Early clinical (through Phase 2)
- Equitable Access | Ensuring continuity
- Equitable Access | Access plans & principles
- Equitable Access | Preparedness & response
- Equitable Access | Territory access commitments
- Business model | Benefit sharing
- Business model | Regulatory strategy
- Business model | Governance
- Business model | Payment Structures
- Protecting & sharing information | Confidentiality
- Protecting & sharing information | Information sharing
- Protecting & sharing information | Publication of Results
- Protecting & sharing information | Technology transfer
- Intellectual Property | License Grants
- Intellectual Property | Ownership of IP
- Intellectual Property | Protection of IP
- Liability | Indemnification & liability
- Liability | Insurance
- Liability | Representations & Warranties
- Term & termination | Effects of termination
- Term & termination | Term of agreement
- Term & termination | Termination & withdrawal
CEPI - Valneva, Chikungunya Vaccine Funding Agreement
2019
Funder
Industry
Industry
Vaccine
Preclinical
Early clinical (through Phase 2)
Early clinical (through Phase 2)
- Equitable Access | Ensuring continuity
- Equitable Access | Access plans & principles
- Equitable Access | Preparedness & response
- Equitable Access | Affordable pricing
- Equitable Access | Territory access commitments
- Business model | Benefit sharing
- Business model | Regulatory strategy
- Business model | Governance
- Business model | Payment Structures
- Protecting & sharing information | Confidentiality
- Protecting & sharing information | Information sharing
- Protecting & sharing information | Publication of Results
- Protecting & sharing information | Technology transfer
- Intellectual Property | License Grants
- Intellectual Property | Ownership of IP
- Intellectual Property | Protection of IP
- Liability | Indemnification & liability
- Liability | Insurance
- Liability | Representations & Warranties
- Term & termination | Effects of termination
- Term & termination | Term of agreement
- Term & termination | Termination & withdrawal
GHIAA2019\MapguideSearch Object
(
[search_parameters] => Array
(
[qs] => CEPI CfP3i Vaccine Funding Agreement Template
)
[filters] => Array
(
[text_search] => CEPI CfP3i Vaccine Funding Agreement Template
)
[child_filters] => Array
(
)
[agreement_args] =>
[provision_args] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[post__in] => Array
(
[0] => 8491
[1] => 8490
[2] => 8489
[3] => 8488
[4] => 8487
[5] => 8486
[6] => 8485
[7] => 8482
[8] => 8481
[9] => 8480
[10] => 8479
[11] => 3736
[12] => 1221
[13] => 1205
[14] => 1204
[15] => 1203
[16] => 1202
[17] => 1159
[18] => 996
[19] => 8491
[20] => 8490
[21] => 8489
[22] => 8488
[23] => 8487
[24] => 8486
[25] => 8485
[26] => 8484
[27] => 8482
[28] => 8481
[29] => 8480
[30] => 8479
[31] => 8469
[32] => 8468
[33] => 8467
[34] => 3757
[35] => 3756
[36] => 3755
[37] => 3754
[38] => 3753
[39] => 3751
[40] => 3749
[41] => 3748
[42] => 3747
[43] => 3746
[44] => 3744
[45] => 3743
[46] => 3736
[47] => 3726
[48] => 3725
[49] => 3724
[50] => 3722
[51] => 1221
[52] => 1205
[53] => 1204
[54] => 1203
[55] => 1202
[56] => 1159
[57] => 996
)
)
[text_agreement_args] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => CEPI CfP3i Vaccine Funding Agreement Template
)
[text_provision_args] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => CEPI CfP3i Vaccine Funding Agreement Template
)
[agreement_ids] => Array
(
)
[agreement_q_rslts] =>
[provision_q_rslts] =>
[text_agreement_q_rslts] => WP_Query Object
(
[query] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => CEPI CfP3i Vaccine Funding Agreement Template
)
[query_vars] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => CEPI CfP3i Vaccine Funding Agreement Template
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[orderby] => title
[order] => ASC
[suppress_filters] =>
[ignore_sticky_posts] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] => 1
[comments_per_page] => 50
[no_found_rows] =>
[search_terms_count] => 6
[search_terms] => Array
(
[0] => CEPI
[1] => CfP3i
[2] => Vaccine
[3] => Funding
[4] => Agreement
[5] => Template
)
[search_orderby_title] => Array
(
[0] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[1] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CfP3i{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[2] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Vaccine{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[3] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Funding{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[4] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Agreement{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[5] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
)
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wpry_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT DISTINCT wpry_posts.*
FROM wpry_posts INNER JOIN wpry_postmeta AS a ON ( a.post_id = wpry_posts.ID ) LEFT JOIN wpry_postmeta AS b ON ( (( b.post_id = a.post_id )) AND (( b.meta_key LIKE CONCAT( '\_', a.meta_key ) )) ) LEFT JOIN wpry_posts AS c ON ( ( c.post_name = b.meta_value ) AND ( c.post_type = 'acf-field' ) AND (( c.post_content LIKE '%:"text"%' ) OR ( c.post_content LIKE '%:"textarea"%' ) OR ( c.post_content LIKE '%:"wysiwyg"%' ) OR ( c.post_content LIKE '%:"checkbox"%' )) )
WHERE 1=1 AND ( ( ( b.meta_id IS NOT NULL ) AND ( c.ID IS NOT NULL ) AND ( a.meta_value LIKE '%CEPI%' ) AND ( a.meta_value LIKE '%CfP3i%' ) AND ( a.meta_value LIKE '%Vaccine%' ) AND ( a.meta_value LIKE '%Funding%' ) AND ( a.meta_value LIKE '%Agreement%' ) AND ( a.meta_value LIKE '%Template%' ) ) OR ( ( ( wpry_posts.post_title LIKE '%CEPI%' ) OR ( wpry_posts.post_content LIKE '%CEPI%' ) OR ( wpry_posts.post_excerpt LIKE '%CEPI%' ) ) AND ( ( wpry_posts.post_title LIKE '%CfP3i%' ) OR ( wpry_posts.post_content LIKE '%CfP3i%' ) OR ( wpry_posts.post_excerpt LIKE '%CfP3i%' ) ) AND ( ( wpry_posts.post_title LIKE '%Vaccine%' ) OR ( wpry_posts.post_content LIKE '%Vaccine%' ) OR ( wpry_posts.post_excerpt LIKE '%Vaccine%' ) ) AND ( ( wpry_posts.post_title LIKE '%Funding%' ) OR ( wpry_posts.post_content LIKE '%Funding%' ) OR ( wpry_posts.post_excerpt LIKE '%Funding%' ) ) AND ( ( wpry_posts.post_title LIKE '%Agreement%' ) OR ( wpry_posts.post_content LIKE '%Agreement%' ) OR ( wpry_posts.post_excerpt LIKE '%Agreement%' ) ) AND ( ( wpry_posts.post_title LIKE '%Template%' ) OR ( wpry_posts.post_content LIKE '%Template%' ) OR ( wpry_posts.post_excerpt LIKE '%Template%' ) ) ) ) AND ((wpry_posts.post_type = 'agreement' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
ORDER BY wpry_posts.post_title ASC
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 994
[post_author] => 7
[post_date] => 2020-05-18 19:52:27
[post_date_gmt] => 2020-05-18 19:52:27
[post_content] =>
[post_title] => CEPI CfP3i Vaccine Funding Agreement Template
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2021-09-15 11:59:18
[post_modified_gmt] => 2021-09-15 11:59:18
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=994
[menu_order] => 0
[post_type] => agreement
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 1
[current_post] => -1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 994
[post_author] => 7
[post_date] => 2020-05-18 19:52:27
[post_date_gmt] => 2020-05-18 19:52:27
[post_content] =>
[post_title] => CEPI CfP3i Vaccine Funding Agreement Template
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2021-09-15 11:59:18
[post_modified_gmt] => 2021-09-15 11:59:18
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=994
[menu_order] => 0
[post_type] => agreement
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 1
[max_num_pages] => 0
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] => 1
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] => 1
[query_vars_hash:WP_Query:private] => 619a2fc23590a10dbe8edff5d9ce4e99
[query_vars_changed:WP_Query:private] => 1
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] => Array
(
[0] => about
[1] => an
[2] => are
[3] => as
[4] => at
[5] => be
[6] => by
[7] => com
[8] => for
[9] => from
[10] => how
[11] => in
[12] => is
[13] => it
[14] => of
[15] => on
[16] => or
[17] => that
[18] => the
[19] => this
[20] => to
[21] => was
[22] => what
[23] => when
[24] => where
[25] => who
[26] => will
[27] => with
[28] => www
)
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
[text_provision_q_rslts] => WP_Query Object
(
[query] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => CEPI CfP3i Vaccine Funding Agreement Template
)
[query_vars] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => CEPI CfP3i Vaccine Funding Agreement Template
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[suppress_filters] =>
[ignore_sticky_posts] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] => 1
[comments_per_page] => 50
[no_found_rows] =>
[search_terms_count] => 6
[search_terms] => Array
(
[0] => CEPI
[1] => CfP3i
[2] => Vaccine
[3] => Funding
[4] => Agreement
[5] => Template
)
[search_orderby_title] => Array
(
[0] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[1] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CfP3i{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[2] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Vaccine{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[3] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Funding{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[4] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Agreement{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
[5] => wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}'
)
[order] => DESC
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wpry_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT DISTINCT wpry_posts.*
FROM wpry_posts INNER JOIN wpry_postmeta AS a ON ( a.post_id = wpry_posts.ID ) LEFT JOIN wpry_postmeta AS b ON ( (( b.post_id = a.post_id )) AND (( b.meta_key LIKE CONCAT( '\_', a.meta_key ) )) ) LEFT JOIN wpry_posts AS c ON ( ( c.post_name = b.meta_value ) AND ( c.post_type = 'acf-field' ) AND (( c.post_content LIKE '%:"text"%' ) OR ( c.post_content LIKE '%:"textarea"%' ) OR ( c.post_content LIKE '%:"wysiwyg"%' ) OR ( c.post_content LIKE '%:"checkbox"%' )) )
WHERE 1=1 AND ( ( ( b.meta_id IS NOT NULL ) AND ( c.ID IS NOT NULL ) AND ( a.meta_value LIKE '%CEPI%' ) AND ( a.meta_value LIKE '%CfP3i%' ) AND ( a.meta_value LIKE '%Vaccine%' ) AND ( a.meta_value LIKE '%Funding%' ) AND ( a.meta_value LIKE '%Agreement%' ) AND ( a.meta_value LIKE '%Template%' ) ) OR ( ( ( wpry_posts.post_title LIKE '%CEPI%' ) OR ( wpry_posts.post_content LIKE '%CEPI%' ) OR ( wpry_posts.post_excerpt LIKE '%CEPI%' ) ) AND ( ( wpry_posts.post_title LIKE '%CfP3i%' ) OR ( wpry_posts.post_content LIKE '%CfP3i%' ) OR ( wpry_posts.post_excerpt LIKE '%CfP3i%' ) ) AND ( ( wpry_posts.post_title LIKE '%Vaccine%' ) OR ( wpry_posts.post_content LIKE '%Vaccine%' ) OR ( wpry_posts.post_excerpt LIKE '%Vaccine%' ) ) AND ( ( wpry_posts.post_title LIKE '%Funding%' ) OR ( wpry_posts.post_content LIKE '%Funding%' ) OR ( wpry_posts.post_excerpt LIKE '%Funding%' ) ) AND ( ( wpry_posts.post_title LIKE '%Agreement%' ) OR ( wpry_posts.post_content LIKE '%Agreement%' ) OR ( wpry_posts.post_excerpt LIKE '%Agreement%' ) ) AND ( ( wpry_posts.post_title LIKE '%Template%' ) OR ( wpry_posts.post_content LIKE '%Template%' ) OR ( wpry_posts.post_excerpt LIKE '%Template%' ) ) ) ) AND ((wpry_posts.post_type = 'provision_document' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
ORDER BY (CASE WHEN wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI CfP3i Vaccine Funding Agreement Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' THEN 1 WHEN wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' AND wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CfP3i{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' AND wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Vaccine{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' AND wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Funding{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' AND wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Agreement{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' AND wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' THEN 2 WHEN wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' OR wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CfP3i{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' OR wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Vaccine{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' OR wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Funding{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' OR wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Agreement{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' OR wpry_posts.post_title LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' THEN 3 WHEN wpry_posts.post_excerpt LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI CfP3i Vaccine Funding Agreement Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' THEN 4 WHEN wpry_posts.post_content LIKE '{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}CEPI CfP3i Vaccine Funding Agreement Template{02bd6e31423cc5292f1f9f62101fc166ecdec8bd007a153de4e5e231f9692669}' THEN 5 ELSE 6 END), wpry_posts.post_date DESC
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 8491
[post_author] => 5
[post_date] => 2023-01-19 11:34:54
[post_date_gmt] => 2023-01-19 11:34:54
[post_content] =>
[post_title] => CEPI CfP3i Vaccine Funding Agreement Template
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-vaccine-funding-agreement-template
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 11:34:54
[post_modified_gmt] => 2023-01-19 11:34:54
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8491
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 8490
[post_author] => 5
[post_date] => 2023-01-19 11:11:46
[post_date_gmt] => 2023-01-19 11:11:46
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-17
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 11:11:46
[post_modified_gmt] => 2023-01-19 11:11:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8490
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 8489
[post_author] => 5
[post_date] => 2023-01-19 10:44:52
[post_date_gmt] => 2023-01-19 10:44:52
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-16
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 10:44:52
[post_modified_gmt] => 2023-01-19 10:44:52
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8489
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 8488
[post_author] => 5
[post_date] => 2023-01-19 10:15:15
[post_date_gmt] => 2023-01-19 10:15:15
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-15
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 10:15:15
[post_modified_gmt] => 2023-01-19 10:15:15
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8488
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 8487
[post_author] => 5
[post_date] => 2023-01-19 09:59:54
[post_date_gmt] => 2023-01-19 09:59:54
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-14
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:59:54
[post_modified_gmt] => 2023-01-19 09:59:54
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8487
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[5] => WP_Post Object
(
[ID] => 8486
[post_author] => 5
[post_date] => 2023-01-19 09:46:36
[post_date_gmt] => 2023-01-19 09:46:36
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-13
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:46:36
[post_modified_gmt] => 2023-01-19 09:46:36
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8486
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[6] => WP_Post Object
(
[ID] => 8485
[post_author] => 5
[post_date] => 2023-01-19 09:39:38
[post_date_gmt] => 2023-01-19 09:39:38
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:39:38
[post_modified_gmt] => 2023-01-19 09:39:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8485
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[7] => WP_Post Object
(
[ID] => 8484
[post_author] => 5
[post_date] => 2023-01-19 09:17:50
[post_date_gmt] => 2023-01-19 09:17:50
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-20
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:17:50
[post_modified_gmt] => 2023-01-19 09:17:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8484
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[8] => WP_Post Object
(
[ID] => 8482
[post_author] => 5
[post_date] => 2023-01-18 16:32:52
[post_date_gmt] => 2023-01-18 16:32:52
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-18 16:32:52
[post_modified_gmt] => 2023-01-18 16:32:52
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8482
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[9] => WP_Post Object
(
[ID] => 8481
[post_author] => 5
[post_date] => 2023-01-18 15:49:38
[post_date_gmt] => 2023-01-18 15:49:38
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 12:07:24
[post_modified_gmt] => 2023-01-19 12:07:24
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8481
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[10] => WP_Post Object
(
[ID] => 8480
[post_author] => 5
[post_date] => 2023-01-17 17:53:00
[post_date_gmt] => 2023-01-17 17:53:00
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:53:00
[post_modified_gmt] => 2023-01-17 17:53:00
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8480
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[11] => WP_Post Object
(
[ID] => 8479
[post_author] => 5
[post_date] => 2023-01-17 17:35:45
[post_date_gmt] => 2023-01-17 17:35:45
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:35:45
[post_modified_gmt] => 2023-01-17 17:35:45
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8479
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[12] => WP_Post Object
(
[ID] => 8469
[post_author] => 5
[post_date] => 2023-01-13 13:35:47
[post_date_gmt] => 2023-01-13 13:35:47
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-19
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 13:35:47
[post_modified_gmt] => 2023-01-13 13:35:47
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8469
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[13] => WP_Post Object
(
[ID] => 8468
[post_author] => 5
[post_date] => 2023-01-11 14:35:38
[post_date_gmt] => 2023-01-11 14:35:38
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-13
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 14:54:13
[post_modified_gmt] => 2023-01-11 14:54:13
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8468
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[14] => WP_Post Object
(
[ID] => 8467
[post_author] => 5
[post_date] => 2023-01-11 14:29:13
[post_date_gmt] => 2023-01-11 14:29:13
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 14:36:41
[post_modified_gmt] => 2023-01-11 14:36:41
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8467
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[15] => WP_Post Object
(
[ID] => 3757
[post_author] => 5
[post_date] => 2021-08-25 08:42:34
[post_date_gmt] => 2021-08-25 08:42:34
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-18
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:47:08
[post_modified_gmt] => 2023-01-11 15:47:08
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3757
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[16] => WP_Post Object
(
[ID] => 3756
[post_author] => 5
[post_date] => 2021-08-25 08:10:37
[post_date_gmt] => 2021-08-25 08:10:37
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-17
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:39:31
[post_modified_gmt] => 2023-01-11 15:39:31
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3756
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[17] => WP_Post Object
(
[ID] => 3755
[post_author] => 5
[post_date] => 2021-08-25 07:55:51
[post_date_gmt] => 2021-08-25 07:55:51
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-16
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:24:11
[post_modified_gmt] => 2023-01-19 09:24:11
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3755
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[18] => WP_Post Object
(
[ID] => 3754
[post_author] => 5
[post_date] => 2021-08-24 13:43:37
[post_date_gmt] => 2021-08-24 13:43:37
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-15
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-12 13:59:38
[post_modified_gmt] => 2023-01-12 13:59:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3754
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[19] => WP_Post Object
(
[ID] => 3753
[post_author] => 5
[post_date] => 2021-08-24 13:14:41
[post_date_gmt] => 2021-08-24 13:14:41
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-14
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 10:13:40
[post_modified_gmt] => 2023-01-19 10:13:40
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3753
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[20] => WP_Post Object
(
[ID] => 3751
[post_author] => 5
[post_date] => 2021-08-24 12:54:56
[post_date_gmt] => 2021-08-24 12:54:56
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-12 13:20:29
[post_modified_gmt] => 2023-01-12 13:20:29
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3751
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[21] => WP_Post Object
(
[ID] => 3749
[post_author] => 5
[post_date] => 2021-08-24 12:40:53
[post_date_gmt] => 2021-08-24 12:40:53
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-12 13:33:44
[post_modified_gmt] => 2023-01-12 13:33:44
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3749
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[22] => WP_Post Object
(
[ID] => 3748
[post_author] => 5
[post_date] => 2021-08-24 12:31:07
[post_date_gmt] => 2021-08-24 12:31:07
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 14:17:38
[post_modified_gmt] => 2023-01-11 14:17:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3748
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[23] => WP_Post Object
(
[ID] => 3747
[post_author] => 5
[post_date] => 2021-08-24 11:12:07
[post_date_gmt] => 2021-08-24 11:12:07
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:28:33
[post_modified_gmt] => 2023-01-11 15:28:33
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3747
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[24] => WP_Post Object
(
[ID] => 3746
[post_author] => 5
[post_date] => 2021-08-24 10:45:05
[post_date_gmt] => 2021-08-24 10:45:05
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:55:51
[post_modified_gmt] => 2023-01-11 15:55:51
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3746
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[25] => WP_Post Object
(
[ID] => 3744
[post_author] => 5
[post_date] => 2021-08-24 10:32:54
[post_date_gmt] => 2021-08-24 10:32:54
[post_content] =>
[post_title] => CEPI - Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2023-03-28 14:06:21
[post_modified_gmt] => 2023-03-28 14:06:21
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3744
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[26] => WP_Post Object
(
[ID] => 3743
[post_author] => 5
[post_date] => 2021-08-24 10:19:00
[post_date_gmt] => 2021-08-24 10:19:00
[post_content] =>
[post_title] => CEPI - Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:53:13
[post_modified_gmt] => 2023-01-11 15:53:13
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3743
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[27] => WP_Post Object
(
[ID] => 3736
[post_author] => 5
[post_date] => 2021-08-24 07:47:09
[post_date_gmt] => 2021-08-24 07:47:09
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 14:46:43
[post_modified_gmt] => 2023-01-13 14:46:43
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3736
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[28] => WP_Post Object
(
[ID] => 3726
[post_author] => 5
[post_date] => 2021-08-23 16:13:39
[post_date_gmt] => 2021-08-23 16:13:39
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:23:48
[post_modified_gmt] => 2023-01-11 15:23:48
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3726
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[29] => WP_Post Object
(
[ID] => 3725
[post_author] => 5
[post_date] => 2021-08-23 13:56:41
[post_date_gmt] => 2021-08-23 13:56:41
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:50:35
[post_modified_gmt] => 2023-01-11 15:50:35
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3725
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[30] => WP_Post Object
(
[ID] => 3724
[post_author] => 5
[post_date] => 2021-08-23 13:11:07
[post_date_gmt] => 2021-08-23 13:11:07
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:27:12
[post_modified_gmt] => 2023-01-11 15:27:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3724
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[31] => WP_Post Object
(
[ID] => 3722
[post_author] => 5
[post_date] => 2021-08-23 12:12:50
[post_date_gmt] => 2021-08-23 12:12:50
[post_content] =>
[post_title] => CEPI - Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:42:28
[post_modified_gmt] => 2023-01-11 15:42:28
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3722
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[32] => WP_Post Object
(
[ID] => 1221
[post_author] => 6
[post_date] => 2020-05-22 20:09:53
[post_date_gmt] => 2020-05-22 20:09:53
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfpi3-template-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:12:53
[post_modified_gmt] => 2023-01-17 17:12:53
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1221
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[33] => WP_Post Object
(
[ID] => 1205
[post_author] => 6
[post_date] => 2020-05-22 19:33:17
[post_date_gmt] => 2020-05-22 19:33:17
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 12:05:50
[post_modified_gmt] => 2023-01-19 12:05:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1205
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[34] => WP_Post Object
(
[ID] => 1204
[post_author] => 6
[post_date] => 2020-05-22 19:31:46
[post_date_gmt] => 2020-05-22 19:31:46
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:26:09
[post_modified_gmt] => 2023-01-19 09:26:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1204
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[35] => WP_Post Object
(
[ID] => 1203
[post_author] => 6
[post_date] => 2020-05-22 19:30:52
[post_date_gmt] => 2020-05-22 19:30:52
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 14:49:22
[post_modified_gmt] => 2023-01-13 14:49:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1203
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[36] => WP_Post Object
(
[ID] => 1202
[post_author] => 6
[post_date] => 2020-05-22 19:28:49
[post_date_gmt] => 2020-05-22 19:28:49
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 14:47:56
[post_modified_gmt] => 2023-01-13 14:47:56
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1202
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[37] => WP_Post Object
(
[ID] => 1159
[post_author] => 6
[post_date] => 2020-05-21 23:14:15
[post_date_gmt] => 2020-05-21 23:14:15
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:13:30
[post_modified_gmt] => 2023-01-17 17:13:30
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1159
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[38] => WP_Post Object
(
[ID] => 996
[post_author] => 7
[post_date] => 2020-05-18 19:58:18
[post_date_gmt] => 2020-05-18 19:58:18
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:16:23
[post_modified_gmt] => 2023-01-17 17:16:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=996
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 39
[current_post] => -1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 8491
[post_author] => 5
[post_date] => 2023-01-19 11:34:54
[post_date_gmt] => 2023-01-19 11:34:54
[post_content] =>
[post_title] => CEPI CfP3i Vaccine Funding Agreement Template
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-vaccine-funding-agreement-template
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 11:34:54
[post_modified_gmt] => 2023-01-19 11:34:54
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8491
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 39
[max_num_pages] => 0
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] => 1
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] => 1
[query_vars_hash:WP_Query:private] => ce67fbca653148efa178ec864b884b00
[query_vars_changed:WP_Query:private] => 1
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] => Array
(
[0] => about
[1] => an
[2] => are
[3] => as
[4] => at
[5] => be
[6] => by
[7] => com
[8] => for
[9] => from
[10] => how
[11] => in
[12] => is
[13] => it
[14] => of
[15] => on
[16] => or
[17] => that
[18] => the
[19] => this
[20] => to
[21] => was
[22] => what
[23] => when
[24] => where
[25] => who
[26] => will
[27] => with
[28] => www
)
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
[provisions] => Array
(
[0] => WP_Post Object
(
[ID] => 8491
[post_author] => 5
[post_date] => 2023-01-19 11:34:54
[post_date_gmt] => 2023-01-19 11:34:54
[post_content] =>
[post_title] => CEPI CfP3i Vaccine Funding Agreement Template
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-vaccine-funding-agreement-template
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 11:34:54
[post_modified_gmt] => 2023-01-19 11:34:54
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8491
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 8490
[post_author] => 5
[post_date] => 2023-01-19 11:11:46
[post_date_gmt] => 2023-01-19 11:11:46
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-17
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 11:11:46
[post_modified_gmt] => 2023-01-19 11:11:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8490
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 8489
[post_author] => 5
[post_date] => 2023-01-19 10:44:52
[post_date_gmt] => 2023-01-19 10:44:52
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-16
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 10:44:52
[post_modified_gmt] => 2023-01-19 10:44:52
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8489
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 8488
[post_author] => 5
[post_date] => 2023-01-19 10:15:15
[post_date_gmt] => 2023-01-19 10:15:15
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-15
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 10:15:15
[post_modified_gmt] => 2023-01-19 10:15:15
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8488
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 8487
[post_author] => 5
[post_date] => 2023-01-19 09:59:54
[post_date_gmt] => 2023-01-19 09:59:54
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-14
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:59:54
[post_modified_gmt] => 2023-01-19 09:59:54
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8487
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[5] => WP_Post Object
(
[ID] => 8486
[post_author] => 5
[post_date] => 2023-01-19 09:46:36
[post_date_gmt] => 2023-01-19 09:46:36
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-13
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:46:36
[post_modified_gmt] => 2023-01-19 09:46:36
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8486
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[6] => WP_Post Object
(
[ID] => 8485
[post_author] => 5
[post_date] => 2023-01-19 09:39:38
[post_date_gmt] => 2023-01-19 09:39:38
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:39:38
[post_modified_gmt] => 2023-01-19 09:39:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8485
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[7] => WP_Post Object
(
[ID] => 8484
[post_author] => 5
[post_date] => 2023-01-19 09:17:50
[post_date_gmt] => 2023-01-19 09:17:50
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-20
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:17:50
[post_modified_gmt] => 2023-01-19 09:17:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8484
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[8] => WP_Post Object
(
[ID] => 8482
[post_author] => 5
[post_date] => 2023-01-18 16:32:52
[post_date_gmt] => 2023-01-18 16:32:52
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-18 16:32:52
[post_modified_gmt] => 2023-01-18 16:32:52
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8482
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[9] => WP_Post Object
(
[ID] => 8481
[post_author] => 5
[post_date] => 2023-01-18 15:49:38
[post_date_gmt] => 2023-01-18 15:49:38
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 12:07:24
[post_modified_gmt] => 2023-01-19 12:07:24
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8481
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[10] => WP_Post Object
(
[ID] => 8480
[post_author] => 5
[post_date] => 2023-01-17 17:53:00
[post_date_gmt] => 2023-01-17 17:53:00
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:53:00
[post_modified_gmt] => 2023-01-17 17:53:00
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8480
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[11] => WP_Post Object
(
[ID] => 8479
[post_author] => 5
[post_date] => 2023-01-17 17:35:45
[post_date_gmt] => 2023-01-17 17:35:45
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:35:45
[post_modified_gmt] => 2023-01-17 17:35:45
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8479
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[12] => WP_Post Object
(
[ID] => 8469
[post_author] => 5
[post_date] => 2023-01-13 13:35:47
[post_date_gmt] => 2023-01-13 13:35:47
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-19
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 13:35:47
[post_modified_gmt] => 2023-01-13 13:35:47
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8469
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[13] => WP_Post Object
(
[ID] => 8468
[post_author] => 5
[post_date] => 2023-01-11 14:35:38
[post_date_gmt] => 2023-01-11 14:35:38
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-13
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 14:54:13
[post_modified_gmt] => 2023-01-11 14:54:13
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8468
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[14] => WP_Post Object
(
[ID] => 8467
[post_author] => 5
[post_date] => 2023-01-11 14:29:13
[post_date_gmt] => 2023-01-11 14:29:13
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 14:36:41
[post_modified_gmt] => 2023-01-11 14:36:41
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=8467
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[15] => WP_Post Object
(
[ID] => 3757
[post_author] => 5
[post_date] => 2021-08-25 08:42:34
[post_date_gmt] => 2021-08-25 08:42:34
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-18
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:47:08
[post_modified_gmt] => 2023-01-11 15:47:08
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3757
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[16] => WP_Post Object
(
[ID] => 3756
[post_author] => 5
[post_date] => 2021-08-25 08:10:37
[post_date_gmt] => 2021-08-25 08:10:37
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-17
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:39:31
[post_modified_gmt] => 2023-01-11 15:39:31
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3756
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[17] => WP_Post Object
(
[ID] => 3755
[post_author] => 5
[post_date] => 2021-08-25 07:55:51
[post_date_gmt] => 2021-08-25 07:55:51
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-16
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:24:11
[post_modified_gmt] => 2023-01-19 09:24:11
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3755
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[18] => WP_Post Object
(
[ID] => 3754
[post_author] => 5
[post_date] => 2021-08-24 13:43:37
[post_date_gmt] => 2021-08-24 13:43:37
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-15
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-12 13:59:38
[post_modified_gmt] => 2023-01-12 13:59:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3754
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[19] => WP_Post Object
(
[ID] => 3753
[post_author] => 5
[post_date] => 2021-08-24 13:14:41
[post_date_gmt] => 2021-08-24 13:14:41
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-14
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 10:13:40
[post_modified_gmt] => 2023-01-19 10:13:40
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3753
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[20] => WP_Post Object
(
[ID] => 3751
[post_author] => 5
[post_date] => 2021-08-24 12:54:56
[post_date_gmt] => 2021-08-24 12:54:56
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-12 13:20:29
[post_modified_gmt] => 2023-01-12 13:20:29
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3751
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[21] => WP_Post Object
(
[ID] => 3749
[post_author] => 5
[post_date] => 2021-08-24 12:40:53
[post_date_gmt] => 2021-08-24 12:40:53
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-12 13:33:44
[post_modified_gmt] => 2023-01-12 13:33:44
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3749
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[22] => WP_Post Object
(
[ID] => 3748
[post_author] => 5
[post_date] => 2021-08-24 12:31:07
[post_date_gmt] => 2021-08-24 12:31:07
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 14:17:38
[post_modified_gmt] => 2023-01-11 14:17:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3748
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[23] => WP_Post Object
(
[ID] => 3747
[post_author] => 5
[post_date] => 2021-08-24 11:12:07
[post_date_gmt] => 2021-08-24 11:12:07
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:28:33
[post_modified_gmt] => 2023-01-11 15:28:33
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3747
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[24] => WP_Post Object
(
[ID] => 3746
[post_author] => 5
[post_date] => 2021-08-24 10:45:05
[post_date_gmt] => 2021-08-24 10:45:05
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:55:51
[post_modified_gmt] => 2023-01-11 15:55:51
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3746
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[25] => WP_Post Object
(
[ID] => 3744
[post_author] => 5
[post_date] => 2021-08-24 10:32:54
[post_date_gmt] => 2021-08-24 10:32:54
[post_content] =>
[post_title] => CEPI - Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2023-03-28 14:06:21
[post_modified_gmt] => 2023-03-28 14:06:21
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3744
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[26] => WP_Post Object
(
[ID] => 3743
[post_author] => 5
[post_date] => 2021-08-24 10:19:00
[post_date_gmt] => 2021-08-24 10:19:00
[post_content] =>
[post_title] => CEPI - Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:53:13
[post_modified_gmt] => 2023-01-11 15:53:13
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3743
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[27] => WP_Post Object
(
[ID] => 3736
[post_author] => 5
[post_date] => 2021-08-24 07:47:09
[post_date_gmt] => 2021-08-24 07:47:09
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 14:46:43
[post_modified_gmt] => 2023-01-13 14:46:43
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3736
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[28] => WP_Post Object
(
[ID] => 3726
[post_author] => 5
[post_date] => 2021-08-23 16:13:39
[post_date_gmt] => 2021-08-23 16:13:39
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:23:48
[post_modified_gmt] => 2023-01-11 15:23:48
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3726
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[29] => WP_Post Object
(
[ID] => 3725
[post_author] => 5
[post_date] => 2021-08-23 13:56:41
[post_date_gmt] => 2021-08-23 13:56:41
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:50:35
[post_modified_gmt] => 2023-01-11 15:50:35
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3725
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[30] => WP_Post Object
(
[ID] => 3724
[post_author] => 5
[post_date] => 2021-08-23 13:11:07
[post_date_gmt] => 2021-08-23 13:11:07
[post_content] =>
[post_title] => CEPI – Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:27:12
[post_modified_gmt] => 2023-01-11 15:27:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3724
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[31] => WP_Post Object
(
[ID] => 3722
[post_author] => 5
[post_date] => 2021-08-23 12:12:50
[post_date_gmt] => 2021-08-23 12:12:50
[post_content] =>
[post_title] => CEPI - Valneva, Chikungunya Vaccine Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-valneva-chikungunya-vaccine-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-11 15:42:28
[post_modified_gmt] => 2023-01-11 15:42:28
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3722
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[32] => WP_Post Object
(
[ID] => 1221
[post_author] => 6
[post_date] => 2020-05-22 20:09:53
[post_date_gmt] => 2020-05-22 20:09:53
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfpi3-template-funding-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:12:53
[post_modified_gmt] => 2023-01-17 17:12:53
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1221
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[33] => WP_Post Object
(
[ID] => 1205
[post_author] => 6
[post_date] => 2020-05-22 19:33:17
[post_date_gmt] => 2020-05-22 19:33:17
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 12:05:50
[post_modified_gmt] => 2023-01-19 12:05:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1205
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[34] => WP_Post Object
(
[ID] => 1204
[post_author] => 6
[post_date] => 2020-05-22 19:31:46
[post_date_gmt] => 2020-05-22 19:31:46
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-19 09:26:09
[post_modified_gmt] => 2023-01-19 09:26:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1204
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[35] => WP_Post Object
(
[ID] => 1203
[post_author] => 6
[post_date] => 2020-05-22 19:30:52
[post_date_gmt] => 2020-05-22 19:30:52
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 14:49:22
[post_modified_gmt] => 2023-01-13 14:49:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1203
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[36] => WP_Post Object
(
[ID] => 1202
[post_author] => 6
[post_date] => 2020-05-22 19:28:49
[post_date_gmt] => 2020-05-22 19:28:49
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-13 14:47:56
[post_modified_gmt] => 2023-01-13 14:47:56
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1202
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[37] => WP_Post Object
(
[ID] => 1159
[post_author] => 6
[post_date] => 2020-05-21 23:14:15
[post_date_gmt] => 2020-05-21 23:14:15
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:13:30
[post_modified_gmt] => 2023-01-17 17:13:30
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1159
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[38] => WP_Post Object
(
[ID] => 996
[post_author] => 7
[post_date] => 2020-05-18 19:58:18
[post_date_gmt] => 2020-05-18 19:58:18
[post_content] =>
[post_title] => CEPI CfP3i Template Funding Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cepi-cfp3i-template-funding-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-17 17:16:23
[post_modified_gmt] => 2023-01-17 17:16:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=996
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[invalid_get] =>
[is_text_search] => 1
[has_agreement_filters] =>
[has_any_agreement_filter] => Array
(
)
[found_agreements] =>
[has_provision_filters] =>
[found_provisions] => 1
[lbl_quick_search:GHIAA2019\MapguideSearch:private] => Search results for:
[lbl_issue:GHIAA2019\MapguideSearch:private] => Issue:
[lbl_key_term:GHIAA2019\MapguideSearch:private] => Key Term:
[lbl_agreement_type:GHIAA2019\MapguideSearch:private] => Agreement Type:
[lbl_partner_type:GHIAA2019\MapguideSearch:private] => Partner Type:
[lbl_technology:GHIAA2019\MapguideSearch:private] => Technology:
[lbl_development_stage:GHIAA2019\MapguideSearch:private] => Development Stage:
[issues_by_id:GHIAA2019\MapguideSearch:private] => Array
(
[101] => WP_Term Object
(
[term_id] => 101
[name] => Access plans & principles
[slug] => equitable-access
[term_group] => 0
[term_taxonomy_id] => 101
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 29
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[100] => WP_Term Object
(
[term_id] => 100
[name] => Affordable pricing
[slug] => pricing
[term_group] => 0
[term_taxonomy_id] => 100
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 28
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[66] => WP_Term Object
(
[term_id] => 66
[name] => Benefit sharing
[slug] => benefit-revenue-sharing
[term_group] => 0
[term_taxonomy_id] => 66
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 9
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[53] => WP_Term Object
(
[term_id] => 53
[name] => Business model
[slug] => business-model
[term_group] => 0
[term_taxonomy_id] => 53
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[84] => WP_Term Object
(
[term_id] => 84
[name] => Confidentiality
[slug] => confidentiality
[term_group] => 0
[term_taxonomy_id] => 84
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 65
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[271] => WP_Term Object
(
[term_id] => 271
[name] => Donation
[slug] => donation
[term_group] => 0
[term_taxonomy_id] => 271
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 5
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[72] => WP_Term Object
(
[term_id] => 72
[name] => Effects of termination
[slug] => effect-of-termination
[term_group] => 0
[term_taxonomy_id] => 72
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 49
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[281] => WP_Term Object
(
[term_id] => 281
[name] => Ensuring continuity
[slug] => ensuring-continuity
[term_group] => 0
[term_taxonomy_id] => 281
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 34
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[46] => WP_Term Object
(
[term_id] => 46
[name] => Equitable Access
[slug] => access-to-medicines
[term_group] => 0
[term_taxonomy_id] => 46
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[278] => WP_Term Object
(
[term_id] => 278
[name] => Governance
[slug] => roles-responsibilities
[term_group] => 0
[term_taxonomy_id] => 278
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 51
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[80] => WP_Term Object
(
[term_id] => 80
[name] => Indemnification & liability
[slug] => indemnity
[term_group] => 0
[term_taxonomy_id] => 80
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 65
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[257] => WP_Term Object
(
[term_id] => 257
[name] => Information sharing
[slug] => information-sharing-information-sharing
[term_group] => 0
[term_taxonomy_id] => 257
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 55
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[109] => WP_Term Object
(
[term_id] => 109
[name] => Insurance
[slug] => insurance
[term_group] => 0
[term_taxonomy_id] => 109
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 37
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[48] => WP_Term Object
(
[term_id] => 48
[name] => Intellectual Property
[slug] => ip-ownership
[term_group] => 0
[term_taxonomy_id] => 48
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[50] => WP_Term Object
(
[term_id] => 50
[name] => Liability
[slug] => liability
[term_group] => 0
[term_taxonomy_id] => 50
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[88] => WP_Term Object
(
[term_id] => 88
[name] => License Grants
[slug] => license-grants
[term_group] => 0
[term_taxonomy_id] => 88
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 66
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[87] => WP_Term Object
(
[term_id] => 87
[name] => Ownership of IP
[slug] => ownership-ip
[term_group] => 0
[term_taxonomy_id] => 87
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 53
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[70] => WP_Term Object
(
[term_id] => 70
[name] => Payment Structures
[slug] => royalties-and-payments
[term_group] => 0
[term_taxonomy_id] => 70
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 50
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[102] => WP_Term Object
(
[term_id] => 102
[name] => Preparedness & response
[slug] => outbreak-preparedness
[term_group] => 0
[term_taxonomy_id] => 102
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 9
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[268] => WP_Term Object
(
[term_id] => 268
[name] => Product supply
[slug] => supply-purchase-of-products
[term_group] => 0
[term_taxonomy_id] => 268
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 30
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[49] => WP_Term Object
(
[term_id] => 49
[name] => Protecting & sharing information
[slug] => information-sharing
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[90] => WP_Term Object
(
[term_id] => 90
[name] => Protection of IP
[slug] => protection-results
[term_group] => 0
[term_taxonomy_id] => 90
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 42
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[290] => WP_Term Object
(
[term_id] => 290
[name] => Publication of Results
[slug] => publication-of-results
[term_group] => 0
[term_taxonomy_id] => 290
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 39
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[56] => WP_Term Object
(
[term_id] => 56
[name] => Regulatory strategy
[slug] => regulatory-strategy
[term_group] => 0
[term_taxonomy_id] => 56
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 37
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[81] => WP_Term Object
(
[term_id] => 81
[name] => Representations & Warranties
[slug] => warranties
[term_group] => 0
[term_taxonomy_id] => 81
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 56
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[86] => WP_Term Object
(
[term_id] => 86
[name] => Technology transfer
[slug] => technology-transfer
[term_group] => 0
[term_taxonomy_id] => 86
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 25
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[52] => WP_Term Object
(
[term_id] => 52
[name] => Term & termination
[slug] => term-and-termination
[term_group] => 0
[term_taxonomy_id] => 52
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[76] => WP_Term Object
(
[term_id] => 76
[name] => Term of agreement
[slug] => term-of-agreement
[term_group] => 0
[term_taxonomy_id] => 76
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 53
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[74] => WP_Term Object
(
[term_id] => 74
[name] => Termination & withdrawal
[slug] => termination-and-withdrawal
[term_group] => 0
[term_taxonomy_id] => 74
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 51
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[282] => WP_Term Object
(
[term_id] => 282
[name] => Territory access commitments
[slug] => territory-access-commitments
[term_group] => 0
[term_taxonomy_id] => 282
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 33
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
)
[issues_by_slug:GHIAA2019\MapguideSearch:private] => Array
(
[equitable-access] => WP_Term Object
(
[term_id] => 101
[name] => Access plans & principles
[slug] => equitable-access
[term_group] => 0
[term_taxonomy_id] => 101
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 29
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[pricing] => WP_Term Object
(
[term_id] => 100
[name] => Affordable pricing
[slug] => pricing
[term_group] => 0
[term_taxonomy_id] => 100
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 28
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[benefit-revenue-sharing] => WP_Term Object
(
[term_id] => 66
[name] => Benefit sharing
[slug] => benefit-revenue-sharing
[term_group] => 0
[term_taxonomy_id] => 66
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 9
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[business-model] => WP_Term Object
(
[term_id] => 53
[name] => Business model
[slug] => business-model
[term_group] => 0
[term_taxonomy_id] => 53
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[confidentiality] => WP_Term Object
(
[term_id] => 84
[name] => Confidentiality
[slug] => confidentiality
[term_group] => 0
[term_taxonomy_id] => 84
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 65
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[donation] => WP_Term Object
(
[term_id] => 271
[name] => Donation
[slug] => donation
[term_group] => 0
[term_taxonomy_id] => 271
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 5
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[effect-of-termination] => WP_Term Object
(
[term_id] => 72
[name] => Effects of termination
[slug] => effect-of-termination
[term_group] => 0
[term_taxonomy_id] => 72
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 49
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[ensuring-continuity] => WP_Term Object
(
[term_id] => 281
[name] => Ensuring continuity
[slug] => ensuring-continuity
[term_group] => 0
[term_taxonomy_id] => 281
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 34
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[access-to-medicines] => WP_Term Object
(
[term_id] => 46
[name] => Equitable Access
[slug] => access-to-medicines
[term_group] => 0
[term_taxonomy_id] => 46
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[roles-responsibilities] => WP_Term Object
(
[term_id] => 278
[name] => Governance
[slug] => roles-responsibilities
[term_group] => 0
[term_taxonomy_id] => 278
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 51
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[indemnity] => WP_Term Object
(
[term_id] => 80
[name] => Indemnification & liability
[slug] => indemnity
[term_group] => 0
[term_taxonomy_id] => 80
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 65
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[information-sharing-information-sharing] => WP_Term Object
(
[term_id] => 257
[name] => Information sharing
[slug] => information-sharing-information-sharing
[term_group] => 0
[term_taxonomy_id] => 257
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 55
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[insurance] => WP_Term Object
(
[term_id] => 109
[name] => Insurance
[slug] => insurance
[term_group] => 0
[term_taxonomy_id] => 109
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 37
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[ip-ownership] => WP_Term Object
(
[term_id] => 48
[name] => Intellectual Property
[slug] => ip-ownership
[term_group] => 0
[term_taxonomy_id] => 48
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[liability] => WP_Term Object
(
[term_id] => 50
[name] => Liability
[slug] => liability
[term_group] => 0
[term_taxonomy_id] => 50
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[license-grants] => WP_Term Object
(
[term_id] => 88
[name] => License Grants
[slug] => license-grants
[term_group] => 0
[term_taxonomy_id] => 88
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 66
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[ownership-ip] => WP_Term Object
(
[term_id] => 87
[name] => Ownership of IP
[slug] => ownership-ip
[term_group] => 0
[term_taxonomy_id] => 87
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 53
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[royalties-and-payments] => WP_Term Object
(
[term_id] => 70
[name] => Payment Structures
[slug] => royalties-and-payments
[term_group] => 0
[term_taxonomy_id] => 70
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 50
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[outbreak-preparedness] => WP_Term Object
(
[term_id] => 102
[name] => Preparedness & response
[slug] => outbreak-preparedness
[term_group] => 0
[term_taxonomy_id] => 102
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 9
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[supply-purchase-of-products] => WP_Term Object
(
[term_id] => 268
[name] => Product supply
[slug] => supply-purchase-of-products
[term_group] => 0
[term_taxonomy_id] => 268
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 30
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[information-sharing] => WP_Term Object
(
[term_id] => 49
[name] => Protecting & sharing information
[slug] => information-sharing
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[protection-results] => WP_Term Object
(
[term_id] => 90
[name] => Protection of IP
[slug] => protection-results
[term_group] => 0
[term_taxonomy_id] => 90
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 42
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[publication-of-results] => WP_Term Object
(
[term_id] => 290
[name] => Publication of Results
[slug] => publication-of-results
[term_group] => 0
[term_taxonomy_id] => 290
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 39
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[regulatory-strategy] => WP_Term Object
(
[term_id] => 56
[name] => Regulatory strategy
[slug] => regulatory-strategy
[term_group] => 0
[term_taxonomy_id] => 56
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 37
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[warranties] => WP_Term Object
(
[term_id] => 81
[name] => Representations & Warranties
[slug] => warranties
[term_group] => 0
[term_taxonomy_id] => 81
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 56
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[technology-transfer] => WP_Term Object
(
[term_id] => 86
[name] => Technology transfer
[slug] => technology-transfer
[term_group] => 0
[term_taxonomy_id] => 86
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 25
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[term-and-termination] => WP_Term Object
(
[term_id] => 52
[name] => Term & termination
[slug] => term-and-termination
[term_group] => 0
[term_taxonomy_id] => 52
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[term-of-agreement] => WP_Term Object
(
[term_id] => 76
[name] => Term of agreement
[slug] => term-of-agreement
[term_group] => 0
[term_taxonomy_id] => 76
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 53
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[termination-and-withdrawal] => WP_Term Object
(
[term_id] => 74
[name] => Termination & withdrawal
[slug] => termination-and-withdrawal
[term_group] => 0
[term_taxonomy_id] => 74
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 51
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[territory-access-commitments] => WP_Term Object
(
[term_id] => 282
[name] => Territory access commitments
[slug] => territory-access-commitments
[term_group] => 0
[term_taxonomy_id] => 282
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 33
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
)
[filter_issues:GHIAA2019\MapguideSearch:private] => Array
(
)
)
